Clinical Trial Update: Voriconazole vs. Amphotericin B in the Treatment of Invasive Aspergillosis [Phase 3]

View source ↗

Summary

This update relates to a Phase 3 randomized trial comparing voriconazole with amphotericin B for invasive aspergillosis that has completed enrollment and status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Invasive Aspergillosis

Drugs mentioned

• Amphotericin B (Amphotericin B)
• VORICONAZOLE (Voriconazole)

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Acquired Immunodeficiency Syndrome, Aspergillosis | Phase 3 | Status: COMPLETED